|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|
|||
 |
 |
Pharmacology and Molecular Sciences Archives 1. Dinkova-Kostova, AT, Jenkins, SN, Wehage, SL, Huso, DL, Benedict,
AL, Stephenson, KK, Fahey, JW, Liu, H, Liby, KT, Honda, T, Gribble,
GW, Sporn, MB, Talalay, PA. Dicyanotriterpenoid induces cytoprotective
enzymes and reduces multiplicity of skin tumors in UV-irradiated mice.
Biochem Biophys Res Commun 2008 Mar 21;367(4):859-65. 1. Chen CS, Korobkova E, Chen H, Zhu J, Jian X,
Tao SC, He C, Zhu H. A proteome chip approach reveals new DNA damage recognition
activities in Escherichia coli. Nat Methods 2008:5(1);69-74. 1. Allen MD, Zhang J. A tunable FRET circuit for
engineering fluorescent biosensors. Angew Chem Int Ed Engl 2008 January:
47(3);500-502. 2. Ananthanarayanan B, Fosbrink M, Rahdar M, Zhang
J. Live-cell molecular analysis of Akt activation reveals roles for activation
loop phosphorylation. J Biol Chem 2007 December; 282(50): 36634-36641. 3. Cordeiro MT, Silva AM, Brito CAA, Nascimento
EJM, Magalhaes MCF, Guimaraes 1. Diaz LA, Foss CA, Thornton K, Nimmagadda S, Endres
CJ, Uzuner O, Seyler TM, Ulrich SD, Conway
J, Bettegowda C, Agrawal N, Cheong I, Zhang X, Ladenson PW, Vogelstein
BN, Mont MA, Zhou S, Kinzler KW, Vogelstein B, Pomper MG. Imaging of musculoskeletal
bacterial infections by [124I]FIAU-PET/CT. PLoS ONE 2007 Oct 10;2(10):e1007. 2. Kerns ML, DePianto D, Dinkova-Kostova AT, Talalay
P, Coulombe PA. Reprogramming of keratin biosysthesis by sulforaphane
restores skin integrity in epidermolysis bullosa simplex. Proc Natl Acad
Sci USA 2007;104:14460-14465. 3. Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict
AL, Min C, Dinkova-Kostova AT. Sulforaphane mobilizes cellular defenses
that protect skin against damage by UV radiation. Proc Natl Acad Sci USA
2007;104:17500-17505. 1. Shin S, Wakabayashi N, Misra V, Biswal S, Lee
GH, Agoston ES, Yamamoto M, Kensler TW. NRF2 modulates AHR signaling:
influence on adipogenesis. Molec. Cell. Biol. 2007 Oct; 27 (20):7188-7197. 1. Mehta NR, Lopez PH, Vyas AA, Schnaar RL. Gangliosides
and Nogo receptors 1. Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M,
Fahey JW, Singh NK, Chen M-SA, Stierer T, Garrett-Mayer E, Argani P, Davidson
NE, Talalay P, Kensler TW, Visvanathan K. Preclinical and clinical evaluation
of sulforaphane for chemoprevention in the breast. Carcinogenesis
2007 July;28:1485-1490. 2. Liby K, Honda T, William CR, Risingsong R, Royce
DB, Suh N, Dinkova-Kostova AT, Stephenson KK, Talalay P, Sundararajan
C, Gribble GW, Sporn MB. Novel semisynthetic analogues of betulinic acid
with diverse cytoprotective, antiproliferative, and proapoptotic activities.
Mol Cancer Ther 2007 Jul;6:2113-2119. 1. Low W-K, Dang Y, Bhat S, Romo D, Liu JO.
Substrate-dependent targeting of 1. Zhu J, Gopinath K, Murali A, Yi G, Hayward SD,
Zhu H, Kao C. RNA-binding proteins that inhibit RNA virus infection. Proc
Natl Acad Sci USA 2007 Feb 27;104:3129-3134. 1. Brignole EJ, Gibson
W. Enzymatic activities of human cytomegalovirus maturational protease
assemblin and its precursor (pPR, pUL80a) are comparable: Maximal activity
of pPR requires self-interaction through its scaffolding domain. J Virol
2007; Feb 7. [Epub ahead of print] 3. Pan F, Sun L, Kardian DB, Whartenby KA, Pardoll
DM, Liu JO. Feedback inhibition of calcineurin and Ras by a dual inhibitory
protein Carabin. Nature 2007;445:433-436. 1. Chikhlikar P, de Arruda LB, Maciel M, Silvera
P, Lewis MG, August JT, Marques ETA. DNA encoding an HIV-1 Gag/human lysosome-associated
membrane protein-1 chimera elicits a broad cellular and humoral immune
response in rhesus. PloS One 2006 Dec;1:e135. 2. Jamieson HA, Hilmer SN, Cogger VC, Warren A,
Cheluvappa R, Abernethy DR, Everitt AV, Fraser R, deCabo R, Le Couteur
DG. Caloric restriction reduces age-related pseudocapillarization of the
hepatic sinusoid. Exp Gerontol 2007; Jan. 2, epub ahead of print. 3. Loveland AN, Nguyen NJ, Brignole EJ, Gibson W.
The amino-conserved domain of human cytomegalovirus UL80a proteins is
required for key interactions during early stages of capsid formatiion
and virus production. J. Virol 2007 Jan;81:620-628. 4. Mager DE, Abernethy DR. Perspectives in pharmacology:
Fast fourier and wavelet transforms in pharmacodynamics. J Pharmacol Exp
Ther 2006; Dec. 1, epub ahead of print. 5. Pan F, Sun L, Kardian DB, Whartenby KA,
Pardoll, DM, Liu JO. Feedback inhibition of calcineurin and Ras by a dual
inhibitory protein Carabin. Nature 2007 Jan; 445:433-436. 1. Collins S, Wolfraim LA, Drake CG, Horton MR,
Powell JD. Cutting edge: transcription. J Immunol 2006 Dec 15;177 (12):8301-8305.
2. Hu X, Addlagatta A, Lu J, Matthews BW, Liu JO.
Elucidation of the function of type 1 human methionine aminopeptidase
during cell cycle progression. Proc Natl Acad Sci USA 2006 Nov 28;103(48):18148-53.
1. Beigi F, Bertucci C, Zhu W, Chakir K, Wainer
IW, Xiao R-P, Abernethy DR. Enantioselective separation and online affinity
chromatographic characterization of R,R- and S,S-fenoterol. Chirality
2006 Nov;18:822-827. 2. Shamay M, Krithivas A, Zhang J, Hayward SD. Recruitment
of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated
herpesvirus LANA. Proc Natl Acad Sci USA 2006 Sept;103:14554-14559. 3. Tao SC, Zhu H. Protein chip fabrication by capture
of nascent polypeptides. Natl Biotechnol 2006 Oct;10:1253-1254. 4. Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov
NM. Atherosclerosis-related molecular alteration of the human Cav1.2 calcium
channel a1C subunit. Proc Nat Acad Sci USA 2006 Nov ;103:17024-17029. 1. Wang J, Loveland AN, Kattenhorn LM, Ploegh HL,
Gibson W. High-molecular-weight protein (pUL48) of human cytomegalovirus
is a competent deubiquitinating protease: mutant viruses altered in its
active-site cysteine or histidine are viable. J Virol 2006;80:6003-6012. 1. Celic I, Masumoto H, Griffith WP, Meluh P, Cotter
RJ, Boeke JD, Verreault A. The sirtuins hst3 and hst4p preserve genome
integrity by controlling histone h3 lysine 56 deacetylation. Current Biology
2006;16:1280-1289. Key words: high-throughput screening, methionine aminopeptidase, X-ray structure, cell proliferation, cancer http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt= Abstract&list_uids=16724298 1. Chong CR, Qian DZ, Pan F, Wei Y, Pili R, Sullivan
DJ, Liu JO. Identification of type 1 inosine monophosphate dehydrogenase
as an antiangiogenic drug target. J Med Chem 2006;49:2677-2680. 1. Mager DE, Wan R, Brown M, Cheng A, Wareski P,
Abernethy DR, Mattson MP. Caloric restriction and intermittent fasting
alter spectral measures of heart rate and blood pressure variability in
rats. FASEB J 2006;20:631-637. 2. Yates MS, Kwak M-K, Egner PA, Groopman JD, Bodreddigari
S, Sutter TR, Baumgartner KJ, Roebuck BD, Yore MM, Honda T, Gribble GW,
Sporn MB, Kensler TW. Potent protection against aflatoxin-induced tumorigenesis
through induction of Nrf2-regulated pathways by the triterpenoid, 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Cancer Res 1. Bond A, Riechart Z, Stivers JT. Novel and specific
inhibitors of a pox virus family type IB topoisomerase. Mol Pharm 2006;69:547-557. 2. Jiang YL, Krosky DJ, Seiple L, Stivers JT. Uracil-directed
ligand tethering: An efficient strategy for human uracil DNA glycosylase
(UNG) inhibitor development. J Am Chem Soc 2005;127:17412-17420. 3. Seiple L, Jaruga P, Dizdaroglu M, Stivers JT.
Linking uracil base excision repair and 5-fluorouracil toxicity in yeast.
Nucleic Acids Res 2006;30:140-151. 1. Dinkova-Kostova AT,
Holtzclaw WD, Kensler TW. The role of Keap1 in cellular protective responses.
Chem Res Toxicol 2005;18:1779-1791. 2. Fahey JW. Moringa oleifera: A review of the medical
evidence for its nutritional, therapeutic, and prophylactic properties,
part 1. Trees for Life Journal 2005;1:5. 3. Kensler TW, Chen J-G, Egner PA, Fahey JW, Jacobson
LP, Stephenson KK, Ye L, Coady JL, Wang J-B, Wu Y, Sun Y, Zhang Q-N, Zhang
B-C, Zhu Y-R, Qian G-S, Carmella SG, Hecht SS, Benning L, Gange SJ, Groopman
JD, Talalay P. Effects of glucosinolate-rich broccoli sprouts on urinary
levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized
clinical trial in He Zuo Township, Qidong, People's Republic of China.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2605-2613. 4. Low WK, Dang, Y, Schneider-Poetsch T, Shi Z,
Choi, NS, Merrick WC, Romo D, Liu, JO. Inhibition of eukaryotic translation
initiation by the marine natural product pateamine A. Molecular Cell 2005;20:709-722. 1. Gibson W. Assembly
and maturation of the capsid. In, Cytomegaloviruses: Molecular Biology
and Immunology. Ed, M. Reddehase. Horizon Scientific Press, Norwich UK.
In press. (2005) 2. Loveland AN, Chan
CK, Brignole EJ, Gibson W. Cleavage of human cytomegalovirus protease
pUL80a at internal and cryptic sites is not essential but enhances infectivity.
J Virol 2005;79:12961-12968. Key words: fluorescence, FRET, PI3K, Akt, phosphoinositides http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt= Abstract&list_uids=16214892 1. Nagarajan R, Kwon K, Nawrot B, Stec WJ, Stivers JT. Catalytic phosphoryl interactions of topoisomerase 1B. Biochemistry 2005;44:11476-11485. Key words: antiviral drugs, pox virus, topoisomerase inhibition, enzyme catalysis, phosphorothioate http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt= Abstract&list_uids=16114884 1. Krosky DJ, Stivers JT. The origins of high affinity
enzyme binding to an extrahelical DNA base. Biochemistry 2005;44:5949-5959.
Key words: DNA repair, uracil DNA glycosylase, uracil flipping, inhibition 2. Vyas AA, Blixt O, Paulson JC, Schnaar RL. Potent
glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth
in vitro. J Biol Chem 2005;280:16305-10. 1. Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw
WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, Sporn
MB, Talalay P. Extremely potent triterpenoid inducers of the phase 2 response:
Correlations of protection against oxidant and inflammatory stress. Proc
Natl Acad Sci USA 2005;102:4584-4589. 1. Cao C, Jiang YL, Song
F, Stivers JT. Dynamic unpairing of DNA during the enzymatic search for
a damaged base. Nature Struct Mol Biol 2004;11:1230-36. 2. Collis SJ, Schwaninger JM, Ntambi AJ, Keller
TW, Nelson WG, Dillehay LE, DeWeese TL. Evasion of early cellular response
mechanisms following low level radiation-induced DNA damage. J Biol Chem
2004;279:49624-32. 3. DiPilato LM, Cheng X, Zhang J. Fluorescent indicators
of cAMP and Epac activation reveal differential dynamics of cAMP signaling
within discretesubcellular compartments. Proc Natl Acad Sci USA 2004;101:16513-18. 4. Gonzalgo ML, Yegnasubramanian S, Yan G, Rogers
CG, Nicol TL, Nelson WG, Pavlovich CP. Molecular profiling and classification
of sporadic renal cell carcinoma by quantitative methylation analysis.
Clin Cancer Res 2004;10:7276-83. 5. Hendrix CW, Collier AC, Lederman MM, Schols D,
Pollard RB, Brown S, Jackson JB, Coombs RW, Glesby MJ, Flexner CW, Bridger
GJ, Badel K, MacFarland RT, Henson GW, Calandra G, AMD3100 HIV Study Group.
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective
CXCR4 receptor inhibitor, in HIV-1 infection. JAIDS 2004; 37(2):1253-1262. 6. Holtzclaw WD, Dinkova-Kostova AT, Talalay P.
Protection against electrophile and oxidative stess by induction of phase
2 genes: the quest for the elusive sensor that responds to inducers. Adv.
Enzyme Regulation 2004;44:335-67. 7. Jiang YL, McDowell L, Poliks B, Studelska DR,
Cao C, Potter GS, Schaefer J, Song F, Stivers JT. Recognition of an unnatural
difluorophenyl nucleotide by uracil DNA glycosylase, Biochemistry 2004;43:15429-38. 8. Kunkel MT, Ni Q, Tsien RY, Zhang J, Newton AC.
Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by
a genetically-encoded fluorescent reporter. J Biol Chem 2004; Dec 6; [Epub
ahead of print] 9. Kwon K, Nagarajan R, Stivers JT. The ribonuclease
activity of vaccinia DNA topoisomerase IB: presteady-state kinetic and
high-throughput inhibition studies using a robust continuous fluorescence
assay. Biochemistry 2004;43:14994-15004. 10. Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs
WB, Luo J, De Marzo AM, Nelson WG, Pavlovich CP. Prostate cancer detection
on urinalysis for alpha-methylacyl coenzyme A racemase protein. J Urol
2004;172:151-3. 1. Fahey JW, Munoz A,
Matsuzaki Y, Suzuki H, Talalay P, Tauchi M, Zhang S, Hurt C, Yanaka A.
Dietary amelioration of Helicobacter pylori infection: design criteria
for a clinical trial. Cancer Epidemiol Biomarkers Prev 2004;13:1610-6. 2. Fannjiang Y, Cheng WC, Lee SJ, Qi B, Pevsner
J, McCaffery JM, Hill RB, Basañez G, Hardwick JM. Mitochondrial
fission proteins regulate programmed cell death in yeast. Genes &
Devel 2004 Nov 15. 3. Gao X, Talalay P. Induction of phase 2 genes
by sulforaphane protects retinal pigment epithelial cells from photo-oxidative
damage. Proc Natl Acad Sci USA 2004;101:10446-51. 4. Hall DA, Zhu H, Zhu X, Royce T, Gerstein M, Snyder
M. Regulation of gene expression by a metabolic enzyme. Science 2004 Oct
15;306:482-4. 5. Mager DE, Abernethy DR, Egan JM, Elahi D. Exendin-4
pharmacodynamics: Insights from the hyperglycemic clamp technique. J Pharmacol
Exp Ther 2004 Nov; 311:830-835. 1. Harry JB, Kobrinsky E, Abernethy DR, Soldatov
NM. New short splice variants of the human
cardiac Cavbeta 2 subunit: Redefining the major functional motifs implemented
in modulation of the Cav1.2 channel. J Biol Chem 2004 Aug 31 [epub ahead
of print]. 2. Kobrinsky E, Kepplinger KJF, Yu A, Harry
JB, Kahr H, Romanin C, Abernethy DR, Soldatov NM. Voltage-gated rearrangements
associated with differential beta-subunit modulation of the L-type Ca
channel. Biophys J 2004;87:844-857. 1. Irusta PM, Lamos E,
Galonek HL, Vander Maten MA, Boersma MC, Chen YB, Hardwick JM. Regulation
of viruses that infect insects. Arch Virol Suppl 2004;(18):171-178. 2.Jiang YL, Cao C, Song F,Ichikawa Y, Stivers JT.
The merits of bipartite transition-state mimics for inhibition of uracil
DNA glycosylase. Bioorg Chem 2004;32:244-262. 3. Seo SY, Chen YB, Ivanovska I, Ranger AM, Hong
SJ, Dawson VL, Korsmeyer SJ, Bellows DS, Fannjiang Y, Hardwick JM. BAD
is a pro-survival factor prior to activation of its pro-apoptotic function.
J Biol Chem 2004;Jul 1. [Epub ahead of print] 4. Stivers JT. Site-specific DNA damage recognition
by enzyme-induced base flipping. Prog Nucleic Acids Res Mol Biol 2004;77:37-65. Key words: Coenzyme A, HAT, p300, mechanism, bisubstrate http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt= Abstract&list_uids=15158807 1. Akasaki K, Nakamura
N, Tsukui N, Yokota S, Murata, SI, Katoh R, Michihara A, Tsuji H, Marques
Jr, ETA, August JT. Human dendritic cell lysosome-associated membrane
protein (hDC-LAMP) expressed in lung type II pneumocytes. Arch Biochem
Biophys 2004;425:147-57. 2. Barros de Arruda L, Chikhlikar PR, August JT,
Marques Jr, ETA. DNA vaccine encoding HIV-1 Gag targeted to the MHC II
compartment by lysosomal-associated membrane protein (LAMP1) elicits enhanced
long-term memory response. Immunology 2004;112:126-33. 3. Hendrix CW, Jackson KA, Whitmore E, Guidos A,
Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. The effect
of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl
estradiol and norethindrone. Clin Pharmacol Ther 2004;75:464-75. 4. Hines AC, Cole PA. Design, synthesis and characterization
of an ATP-peptide conjugate inhibitor of protein kinase A. Bioorg Med
Chem Lett 2004;14:2951-2954. 5. Hwang Y, Cole PA. Efficient synthesis of phosphorylated
prodrugs with bis(POM)-phosphoryl chloride. Org. Letters 2004;6:1555-1556. 6. Kensler TW, Talalay P. Inducers of enzymes that
protect against carcinogens: Drug and food based approaches with dithiolethiones
and sulforaphane. In: Cancer Chemopreventive Agents 1: Promising Cancer
Chemopreventive Agents, edited by Kelloff GJ, Hawk ET, Sigman CC., Humana
Press, NJ, pp. 3-20 (2004). 7. Walser M, Thorpe B. Coping with Kidney Disease.
Wiley & Sons, 2004, 230 pages. 8. Zoete V, Rougee M, Dinkova-Kostova AT, Talalay
P, Bensasson RV. Redox ranking of inducers of a cancer protective enzyme
via the energy of their highest occupied molecular orbital. Free Radic
Biol Med 2004;36:1418-1423. 1.Dinkova-Kostova AT, Fahey JW, Talalay P. Chemical
structures of inducers of 2. Fahey JW, Dinkova-Kostova AT, Stephenson KK,
Talalay P. The "prochaska" microtiter plate bioassay for inducers
of NQ01. Methods in Enzymology 2004;382:243-258. 3. Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA,
Hayward SD. Inhibition of Epstein-barr virus induced growth proliferation
by an EBNA2-TAT peptide. Proc Natl Acad Sci USA 2004;101:4625-4630. 4. Krosky DJ, Schwarz FP, Stivers JT. Linear free
energy correlations for enzymatic base flipping: How do damaged base pairs
facilitate specific recognition? Biochemistry 2004;43:4188-4195. 5. Talalay P, Dinkova-Kostova AT. Role of nicotinamide
quinone oxidoreductase 1 (NQ01) in protection against toxicity of electrophiles
and reactive oxygen intermediates. Methods in Enzymology 2004:382;355-363. 6. Thompson PR, Wang D, Wang L, Fulco M, Pediconi
N, Zhang D, An W, Ge Q, Roeder RG, Wong J, Levrero M, Sartorelli V, Cotter
RJ, Cole PA. Regulation of p300 HAT domain via a novel activation loop.
Nature Struct Mol Biol 2004;11:308-315. 7. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw
WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P. Protection
against electrophile and oxidant stress by induction of the phase 2 response:
Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl
Acad Sci USA 2004;101:2040-2045. 8. Zheng Y, Thompson PR, Cebrat M, Wang L, Devlin
MK, Alani RM, Cole PA. Selective HAT inhibitors as mechanistic tools for
protein acetylation. Meth Enz 2004;376:188-199. Key words: malaria, plasmodium, trioxane, antimalarial, chemotherapy http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= pubmed&dopt=Abstract&list_uids=14971910 1. Urquidi-Macdonald M, Mager DE, Mascelli MA, Frederick B, Freedman J, Fitzgerald DJ, Kleiman NS, Abernethy DR. Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability. Clin Pharmacol Ther 2004;75:60-69. Key words: abciximab, pharmacodynamics, neural network, platelets http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids= 14749692&dopt=Abstract 1. Cole PA, Shen K, Qiao
Y, Wang D. Protein tyrosine kinases Src and Csk: A tail's tale. Curr Opin
Chem Biol 2003;7:580-5. 2. Mager DE, Mascelli MA, Kleiman NS, Fitzgerald
DJ, Abernethy DR. Simultaneous modeling of abciximab plasma concentrations
and ex vivo pharmacodynamics in patients undergoing coronary angioplasty.
J Pharmacol Exp Ther 2003;307:969-76. 3. Nagababu E, Ramasamy S, Abernethy DR, Rifkind
JM. Active nitric oxide produced in the red cell under hypoxic conditions
by deoxyhemoglobin mediated nitrite reduction. J Biol Chem 2003;278:46349-56,2003. 4. Rufo PA, Lin PW, Andrade A, Jiang L, Rameh L,
Flexner CW, Alper SL, Lencer WI. Diarrhea-associated HIV-1 aspartyl protease-inhibitors
potentiate muscarinic Cl- secretion by T84 cells via prolongation of cytosolic
Ca2+ signaling. Am J Physiol Cell Physiol 2003 Dec 30;[Epub ahead of print]. 5. Shen K, Cole PA. Conversion of a tyrosine kinase
protein substrate to a high affinity ligand by ATP linkage. J Am Chem
Soc 2003;125:16172-3. 6. Thayer JF, Merritt MM, Sollers JJ, Zonderman
AB, Evans MK, Yie S, Abernethy DR. Effect of angiotensin converting enzyme
insertion/deletion polymorphism DD genotype on high-frequency heart rate
variability in African Americans. Am J Cardiol 2003;92:1487-90. 7. Zheng W, Zhang Z, Ganguly, S, Weller, JL, Klein
D, Cole PA. Cellular stabilization of the melatonin rhythm enzyme induced
by non-hydrolyzable phosphonate incorporation. Nature Structural Biology
2003;10:1054-7. 1. Benson CA, Williams PL, Currier JS, Holland F,
Mahon LF, MacGregor RR,Inderlied CB, Flexner C, Neidig J, Chaisson R,
Notario GF, Hafner R. A prospective, randomized trial examining the efficacy
and safety of clarithromycin in combination with ethambutol, rifabutin,
or both for the treatment of disseminated Mycobacterium avium complex
disease in persons 2. Cao C, Kwon K, Jiang YL, Stivers JT. Solution
structure and base perturbation studies reveal a novel mode of alkylated
base recognition by 3-methyladenine DNA glycosylase I. J Biol Chem 2003;278:48012-48020. 3. Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch
JM, Petty BG, Fleisher LA, Schein OD. Risks and benefits of anticoagulant
and antiplatelet medication use before cataract surgery. Ophthalmology
2003;110:1784-1788. 4. Kwak MK, Wakabayashi N, Greenlaw, JL, Yamamoto
M, Kensler TW. Antioxidants Key words: DNA repair, uracil DNA glycosylase, transition-state inhibitor, 1-azadeoxyribose, crystal structure http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&list_uids=14580190&dopt=Abstract 1. Bakshi RP, Shapiro
TA. DNA topoisomerases as targets for antiprotozoal therapy. Mini Rev
Med Chem 2003;6:597-608. 2. Davies A, Kalb S, Liang B, Aldrich CJ, Lemonnier
FA, Jiang H, Cotter RJ, Soloski MJ. A peptide from heat shock protein
60 is the dominant peptide bound to Qa-1 in the absence of the MHC class
1a leader sequence peptide Qdm. J Immunol 2003;170:5027-5033. 3. Moyer SC, Von Seggern CE, Cotter RJ. Fragmentation
of cationized phosphotyrosine containing peptides by atmospheric pressure
MALDI/ion trap mass spectrometry. J Am Soc Mass Spectrom 2003;14:581-592. 4. Nenortas E, Kulikowicz T, Burri C, Shapiro TA.
Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions.
Antimicrob Agents Chemother 2003;47:3015-3017. 5. Violin JD, Zhang J, Tsien, RY, Newton,AC. A genetically
encoded fluorescent reporter reveals oscillatory phosphorylation by protein
kinase C. J Cell Biol 2003;161:899-909. 6. Von Seggern CE, Cotter RJ. Fragmentation studies
of non-covalent sugar-sugar complexes by infrared atmospheric pressure
MALDI. J Am Soc Mass Spectrom 2003;14:1158-1165. 7. Von Seggern CE, Moyer SC, Cotter RJ. Liquid infrared
atmospheric pressure MALDI/ion trap mass spectrometry of sialylated oligosaccharides.
Annal Chem 2003;75:3212-3218. 1. Dimick JB, Swoboda
S, Talamini MA, Pelz RK, Hendrix CW, Lipsett PA. Risk of colonization
of central venous catheters: catheters for total parenteral nutrition
vs other catheters. Am J Crit Care 2003;4:328-335. 2. Zheng W, Cole PA. Novel bisubstrate analog inhibitors
of serotoninn-acetyltransferase: The importance of being neutral. Bioorg
Chem 2003;31:398-411. 1. Cebrat M, Kim CM,
Thompson PR, Daugherty M, Cole PA. Synthesis and analysis of potential
prodrugs of coenzyme A analogs for the inhibition of histone acetyltransferase
p300. Bioorg Med Chem 2003;11:3307-3313. 2. Cole PA, Courtney AD, Zhang Z, Qiao Y, Lu W,
Williams DM. Chemical approaches to reversible protein phosphorylation.
Acc Chem Res 2003;36:444-452. 3. Kaehlcke K, Dorr A, Hetzer-Egger C, Kiermer V,
Henklein P, Schnoelzer M, Loret E, Cole PA, Verdin E, Ott M. Acetylation
of Tat defines a cyclin T1-independent step in HIV transactivation. Mol
Cell 2003;12:167-176. 4. Stivers JT, Jiang YL. A mechanistic perspective
on the chemistry of DNA repair glycosylases. Chem Rev 2003;103:2729-2759. 1. Bodley AL, Chakraborty
AK, Xie S, Burri C, Shapiro TA. An unusual type IB topoisomerase from
African trypanosomes. Proc Natl Acad Sci USA 2003;100(13):7539-7544. 2. Kwon K, Cao C, Stivers JT. A novel "zinc
snap" motif conveys structural stability to 3-methyladenine DNA glycosylase
I. J Biol Chem 2003;278(21):19442–6. 3. Moyer SC, Von Seggern CE, Cotter RJ. Fragmentation
of cationized phosphotyrosine containing peptides by atmospheric pressure
MALDI/Ion trap mass spectrometry. JASMS 2003;14:581-92. 4. Posner GH, Paik IH, Sur S, McRiner AJ, Borstnik
K, Xie S, Shapiro TA. Orally active, antimalarial, anticancer, artemisinin-derived
trioxane dimmers with high stability and efficacy. J Med Chem 2003; 46(6):1060-5. 5. Rajagopalan P, Pelz RK, Lipsett PA, Swoboda SM,
Rinaldi MG, Hendrix CW. Enteral fluconazole population pharmacokinetics
in patients in the surgical intensive care unit. Pharmacotherapy 2003;
23(5):592-602. 6. Scheibner KA, Zhang Z, Cole P A. Merging FRET
and expressed protein ligation to analyze protein-protein interactions.
Annal Biochem 2003;317:226-32. 7. Stivers JT, Jiang YL. A mechanistic perspective
on the chemistry of DNA repair glycosylases. Chem Rev 2003;103(7):272-60. 8. Washington CB, Flexner C, Sheiner LB, Rosenkranz
SL, Segal Y, Aberg JA, Blaschke TF. Effect of simultaneous versus staggered
dosing on pharmacokinetic interactions of protease inhibitors. Clin Pharmacol
Ther 200;73(5):406-16. 1. Cotter RJ, English RD, Warscheid B, Hardy A,
Gardner BD. Miniaturized time-of-flight mass spectrometers for bioagent
detection and identification. J Mass Spectrom Soc Japan 2003; 51:36-41. 2. Georges SA, Giebler HA, Cole PA, Luger K, Laybourn
PJ, Nyborg JK. Tax recruitment of CBP/p300, via the KIX domain, reveals
a potent requirement for acetyltransferase activity that is chromatin
dependent and histone tail independent. Mol Cell Biol 2003; 23(10): 3392-404.
3. Hamzeh FM, Benson C, Gerber J, Currier J, McCrea
H, Deutsch P, Ruan P, Wu H, Lee J, Flexner C. Steady-state phamacokinetic
interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther
2003; 73 (3): 159-69. 4. Han A, Pan F, Stroud JC, Youn HD, Liu JO, Chen
L. Sequence-specific recruitment of transcriptional co-repressor Cabin1
by myocyte enhancer factor-2. Nature 2003 Apr 17; 422 (6933): 730-4. 5. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J. A
role for cofactor-cofactor and cofactor-histone interactions in targeting
p300, SWI/SNF and mediator for transcription. EMBO J 2003 May 1; 22 (9):
2146-2155. 6. Jackson JB, Barnett S, Piwowar-Manning
E, Apuzzo L, Raines C, Hendrix C, Hamzeh F, Gallant J. A phase I/II study
of nevirapine for pre-exposureprophylaxis of HIV-1 transmission in uninfected
subjects at high risk. AIDS 2003 Mar 7; 17 (4): 547-53. 7. Jiang YL, Stivers JT. Epimerization of aromatic
C-nucleosides with electron-withdrawing substituents with trifluoroacetic
acid-benzenesulfonic acid using mild conditions. Tetrahedron Lett 2003;
44: 4051-4055. 8. Kwon K, Jiang Y L, Stivers JT Rational engineering
of a DNA glycosylase specific for unnatural cytosine: pyrene base pairs.
Chem and Biol 2003; 10: 351-359. 9. Lee KC, Li J, Cole PA, Wong J, Kraus WL. Transcriptional
activation by thyroid hormone receptor-beta involves chromatin remodeling,
histone acetylation, and synergisticstimulation by p300 and steroid receptor
coactivators. Mol Endocrinol 2003; 17 (5): 908-22. 10. Lu W, Shen K, Cole PA. Chemical dissection of
the effects of tyrosine phosphorylation of SHP-2. Biochemistry 2003 May
13; 42 (18): 5461-8. 11. Lu Y, Raviprakash K, Leao IC, Chikhlikar PR,
Ewing D, Anwar A, Chougnet C, Murphy G, Hayes CG, August JT, Marques ETA.
Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment
elicits long-lasting neutralizing antibodies. Vaccine 2003; 21: 2187-2198. 1. Kwak, MK, Wakabayashi,
N, Itoh, K, Motohashi, H, Yamamoto, M and Kensler, TW. Modulation of gene
expression by cancer chemopreventive dithiolethiones through the Keap1-
and Nrf2 pathway: Identification of novel gene clusters for cell survival.
J Biol Chem 2003; 278: 8135-8145. 2. Que-Gewirth, NLS, Karbarz, MJ, Kalb, SR, Cotter,
RJ and Raetz, CRH. Origin of the 2-aminogluconante Unit in Rhizobium Leguminosarum
Lipid A: Expression cloning of the Outer Membrane Oxidase LpxQ. J. Biol.
Chem. 2003; 278:12120-12129. 3. Ramos-Gomez M, Dolan PM, Itoh K, Yamamoto M,
Kensler TW. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA
adducts and tumor yield in mice. Carcinogenesis 2003; 24:461-467. |
